The existence of a parasitic strategy to counteract host SLC11A1 action reinforces the involvement of the latter in the in vivo control of infection by Leishmania (Vidal et al., 1995; Searle et al., 1998; White et al., 2005), as mentioned previously. The gene discussed is SLC11A1; the disease is infection.